Samsung Medical Center
Samsung Medical Center
Republic of Korea, Seoul
Ki Woong Sung
28 years of experience
Clinic is certified :
Wilms tumor (nephroblastoma) treatment cost in Republic of Korea typically involves complex diagnostics of nephroblastoma starting from $1,000 to $2,000 and chemotherapy for breast cancer (often used in pediatric protocols) which runs from $19,200 to $41,000. Total expenses depend on the tumor stage, surgical approach, and the specific clinic tier. Patients often save 30-50% compared to the US. Top treatment centers are located in Seoul and Seongnam.
Typical Wilms Tumor (Nephroblastoma) Treatment Costs in Republic of Korea
Bookimed Expert Insight: Patients requiring advanced precision surgery benefit from centers like Samsung Medical Center. They utilize Da Vinci robotic systems for nephrectomies within a multidisciplinary cancer center. For families seeking digital-first care, Seoul National University Bundang Hospital (SNUBH) offers a completely paperless system. This high-tech infrastructure supports efficient coordination for complex pediatric oncology cases. National state facilities like Seoul National University Hospital (SNUH) are best for high-risk protocols. They provide presidential-level medical care and extensive pediatric specialization.
| Republic of Korea | Turkey | Austria | |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Wilms tumor (Nephroblastoma) treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Wilms tumor (Nephroblastoma) treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Wilms tumor (Nephroblastoma) treatment journey.
The doctor is a pediatrician with a specialization in bone marrow transplantation and brain tumor treatment. Graduating with a Bachelor of Medicine, a Master's degree, and a PhD from Seoul National University, the doctor has extensive experience in both clinical practice and research.
Professional experience includes serving as a pediatrician at Samsung Medical Center, an Assistant Professor in the Department of Pediatrics at Samsung Clinic, and a researcher at the Oncology Center of Indiana University School of Medicine. The doctor has held leadership roles such as Head of the Children's Oncology Department at Samsung Hospital and currently serves as Head of the Department of Pediatrics at Samsung Clinic.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
The 5-year overall survival rate for Wilms tumor in South Korea ranges from 83% to 87.5% across national studies. These outcomes reflect advanced pediatric oncology protocols. Centers like Seoul National University Hospital maintain high statistics for cancer treatment and use digital systems to improve patient safety.
Bookimed Expert Insight: Samsung Medical Center serves over 2 million patients annually and ranks among the World's Best Hospitals. Its large patient volume suggests higher clinical experience with rare pediatric cases. Choosing a center with ISO and KOIHA accreditations ensures the facility meets international safety standards for complex tumor treatments.
Patient Consensus: Patients note that outcomes are generally excellent in South Korea due to modern infrastructure. They recommend confirming whether a center follows standardized international protocols like COG or SIOP to ensure surgical and chemotherapy consistency.
Samsung Medical Center, Seoul National University Hospital (SNUH), and Seoul National University Bundang Hospital (SNUBH) are recognized for superior pediatric Wilms tumor outcomes. These Newsweek-ranked facilities employ multidisciplinary teams. They use the da Vinci surgical system and IGRT for precise treatment.
Bookimed Expert Insight: Patient volume is a major quality indicator in Seoul. SNUH serves over 10,000 patients daily. This massive scale ensures surgeons manage rare pediatric tumors more frequently than smaller regional centers. This constant practice typically leads to more refined surgical techniques in complex renal removals.
Patient Consensus: Parents emphasize choosing high-volume university hospitals where surgery and chemotherapy are coordinated in one place. They suggest getting a second opinion from major referral centers to ensure treatment plans are consistent.
Wilms tumor treatment protocols involve multimodal care combining chemotherapy, surgery (nephrectomy), and radiation therapy. Teams tailor the approach based on histology and staging. Major centers like Samsung Medical Center use the Da Vinci system for precise surgical interventions to preserve vital kidney function.
Bookimed Expert Insight: Diagnostic precision significantly impacts budget planning in Korea. Complex diagnostic packages for nephroblastoma range from $1,000 to $1,950. Establishing the tumor's exact location and stage early helps determine if preoperative chemotherapy is necessary, which can affect the total surgical complexity and length of hospital stays.
Patient Consensus: Families note that the treatment plan often stays flexible until pathology results arrive after surgery. Patients emphasize preparing for chemotherapy side effects like fatigue and suggest focusing on long-term kidney function monitoring.
South Korean pediatric centers offer robotic and laparoscopic nephrectomies for Wilms tumor. Surgeries utilize the Da Vinci surgical system at JCI-accredited and Newsweek-ranked facilities. These minimally invasive techniques reduce pain and accelerate recovery. Specialized multidisciplinary boards determine eligibility based on tumor size and stage.
Bookimed Expert Insight: While South Korea ranks high for medical technology, pediatric oncologists there maintain a conservative stance. Data shows major centers like Samsung Medical Center handle over 45,000 surgeries yearly. These high volumes allow specialists to select robotic approaches only when safety is guaranteed. Patients should prioritize clinics with integrated pediatric cancer centers for the best multidisciplinary outcomes.
Patient Consensus: Patients note that Korean specialists prioritize surgical safety over cosmetic results in children. It is helpful to ask the oncology team directly why a specific surgical method was chosen for your child's stage.
Wilms tumor treatment in South Korea typically begins with a 1 to 7 day diagnostic phase. Initial treatment follows within roughly 14 days of diagnosis. The entire active process including surgery and chemotherapy generally spans several months. Specific timelines depend on the cancer stage and individual risk group.
Bookimed Expert Insight: Leading centers like Samsung Medical Center and Seoul National University Hospital operate at immense scale, serving millions of patients yearly. This high volume allows these facilities to perform over 30,000 to 45,000 operations annually. For families, this institutional experience means diagnostic protocols are highly streamlined. Patients can often complete complex nephroblastoma diagnostics and move to surgery faster than in lower-volume international centers.
Patient Consensus: Parents note that active treatment timelines vary significantly if chemotherapy is required before surgery. They emphasize clarifying whether the schedule involves outpatient visits or extended inpatient stays for recovery.
English fluency is high among pediatric oncologists and surgeons at Korean tertiary centers. Specialists at Seoul National University Hospital often have international training. Clinical communication is reliable in major Seoul facilities. However, support staff proficiency widely varies across nursing teams and wards.
Bookimed Expert Insight: While surgeons at Seoul National University Hospital often speak excellent English, the bedside logistics are where communication gaps occur. Our data shows hospitals with presidential standards, like Samsung Medical Center, integrate English-proficient staff more deeply into oncology wards. For Wilms tumor cases, request that post-operative instructions be provided in writing during the pre-surgical meeting.
Patient Consensus: Patients note that while the lead surgeon is easy to understand, nurses and residents often rely on translation tools. Families highly recommend using hospital interpreters for detailed consent discussions and discharge planning.